This application relates to agents capable of specifically recognizing GPlba, a key receptor required for platelet adhesion and aggregation. More specifically, this application relates to monoclonal antibodies and derivatives thereof capable of specifically recognizing both the murine and the human GPlba. These monoclonal antibodies and derivatives are particularly useful in the treatment or prevention of thrombosis as well as research tools.